Coronary Artery Disease Clinical Trials in Birmingham, Alabama

5 studies are recruiting for coronary artery disease in Birmingham, Alabama right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Product Surveillance Registry

    The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by str…

    Stage
    Not phased
    Ages
    Any age
    Site
    Research site, Birmingham, Alabama
    Locations
    401 in total
    Run by
    Medtronic
  2. Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.

    This is a two-part study, comprised of an initial open-label run-in phase (Part 1) in a subset of 3 subjects to provide first data regarding safety, and feasibility of the percutaneous endovascular catheter-facilitated intramyocardial delivery of XC001 in patients with RA due to obstructive CAD. Pa…

    Stage
    Phase 2
    Ages
    18 to 85
    Site
    Alabama Cardiology PC, Birmingham, Alabama
    Locations
    14 in total
    Run by
    XyloCor Therapeutics, Inc.
  3. Prevail Global Study

    The purpose of the study is to evaluate the clinical safety and efficacy of the Prevail DCB.

    Stage
    Not phased
    Ages
    18 and older
    Site
    The University of Alabama at Birmingham, Birmingham, Alabama
    Locations
    51 in total
    Run by
    Medtronic Vascular
  4. The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial

    Heart disease remains the leading cause of death in Veterans. Inflammation in the arteries of the heart may increase the risk of cardiac death. Patients with heart disease undergoing major surgery are at increased risk of complications after surgery, including heart attack, stroke, and death. The p…

    Stage
    Phase 4
    Ages
    18 and older
    Site
    Birmingham VA Medical Center, Birmingham, AL, Birmingham, Alabama
    Locations
    9 in total
    Run by
    VA Office of Research and Development
  5. MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

    A Prospective, Multicenter, Randomized, Two-Arm, Single-blind Superiority Trial to Evaluate the Safety and Efficacy of the MagicTouch™ Sirolimus- Coated Balloon in the Treatment of Coronary Drug-Eluting Stent In-Stent Restenosis. Subjects with prior DES implantation presenting with ISR lesions unde…

    Stage
    Not phased
    Ages
    18 to 110
    Site
    Cardiology, PC - Princeton Baptist Medical Center, Birmingham, Alabama
    Locations
    28 in total
    Run by
    Concept Medical Inc.

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.